Stock Information
Kymera Therapeutics Inc (KYMR)
Ticker Symbol: KYMR
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $6,144.45 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.6783
Revenue (TTM): $0.44 M
Dividend Yield: N/A%
ROE: -29.07%
Latest News
-
Kymera: 'Strong Buy' On Continued Success With KT-621 In Th2-Driven Disorders
Mon, Apr 13, 2026 3:12 PM
-
The FDA Grants Fast Track Designation For Kymera Therapeutics' KT-621 For Moderate to Severe Asthma
Mon, Apr 13, 2026 7:03 AM
-
Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma
Mon, Apr 13, 2026 7:01 AM
Key Financials
Financial data not available
